GlassScriptPhysician profile
Savannah Perez
NPI 1215522966
$5,985.94
in general payments reported to CMS, 2019-2025
38 companies · $1,513 in 2025
The $1,513 reported for 2025 was more than what 89% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $631 · 2022: $797 · 2023: $1,580 · 2024: $1,464 · 2025: $1,513.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,557.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,557.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,221.61 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $849.72 | 2021-2025 | |
| Lilly USA, LLC | $593.23 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Astrazeneca Pharmaceuticals LP | $588.91 | 2021-2025 | Airsupra, Farxiga, Breztri |
| Pfizer INC. | $403.66 | 2021-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $294.03 | 2021-2025 | Jardiance |
| Viiv Healthcare Company | $192.58 | 2024-2025 | Apretude |
| Exact Sciences Corporation | $185.51 | 2023-2025 | Cologuard Collection Kit |
| Idorsia Pharmaceuticals US INC | $155.99 | 2022-2023 | Quviviq |
| Bayer Healthcare Pharmaceuticals INC. | $149.33 | 2023-2025 | |
| Incyte Corporation | $129.37 | 2021 | |
| Glaxosmithkline, LLC. | $110.26 | 2023-2025 | Shingrix, Arexvy |
| Amgen INC. | $105.05 | 2023-2025 | Otezla, Repatha, Repatha |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $98.54 | 2023-2025 | Xifaxan |
| Verity Pharmaceuticals INC. | $93.89 | 2024-2025 | Tlando |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Savannah Perez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.